Reckitt Benckiser Healthcare International Ltd, Berkshire
| Държава: | ----- |
| Кратка информация: | Reckitt Benckiser is a global success story: a world leader in the global household, health and personal care sectors. Our offer is simple - bigger, better and more competitive opportunities to develop a rewarding career at the very forefront of FMCG. We are listed on the UK stock exchange and are a FTSE top 25 company. Our success is led by our Powerbrands - big-name brands like Finish, Vanish, Durex, Dettol, Lysol, Harpic, Mortein, Gaviscon, Scholl and Veet that aim to achieve global market leadership. Through them we've become No.1 and No. 2 in the vast majority of markets and categories in which we compete. Backing up our Powerbrands is a great portfolio of local hero brands. We operate in over 60 countries, while our brands are sold in almost 200. Our people are the power behind these brands - around 27,000 talented, driven and entrepreneurial individuals, all working together. Globally, RB sold 20 million products a day in 2010. Our future In the future we'll continue our relentless focus on powerful brands in fast-growing categories. We'll keep delighting consumers with solutions to everyday problems. Our people, highly motivated and well rewarded, will continue to enjoy real ownership of their achievements. Meanwhile we continue to look for talented, entrepreneurial and dynamic people worldwide to hit the ground running. We're driven by innovation: typically about 30–40% of net revenue comes from innovations launched in the three previous years. Opportunities range from professionals in sales and marketing, research and development, supply chain and to experts in information services, finance and human resources. We are only looking for true talent: people hungry for the opportunity and freedom to make their mark. It's going to be an exciting journey - and you could be part of it. |
| Сайт: | http://www.rb.com/home |
Търсене в сайта
Лекарствен справочник
http://sommons.co/out?zoneId=2647810-2647961 Банер II
